Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nu.Q® Vet Cancer Test Product Brochure (US)

Sunday, April 6, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Volition has submitted a manuscript for the Nu.Q® Vet Cancer Test in cats, which is anticipated to unlock a $5 million milestone payment upon publication in a peer-reviewed journal. Additionally, the company has announced the first automated version of the test in collaboration with Fujifilm Vet Systems, marking a significant advancement in veterinary diagnostics.
Price reaction · baseline $10.646 (2025-04-04 close) · 1 other VNRX headline(s) in the window, move may be shared
day 0 close
-6.1%
day 1 · peak
-13.6%
day 3
-9.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Submission of manuscript expected to unlock $5 million milestone payment.
  • First automated Nu.Q® Vet Cancer Test developed with Fujifilm Vet Systems.
  • Potential for significant advancements in veterinary cancer diagnostics.

Full Press Release Details

Related Articles

• Press Releases Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment
• Press Releases Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

Volition Announces Submission of Manuscript for Nu.Q® Vet Cancer Test in Cats. The publication of this study in a peer reviewed journal is expected subsequently to unlock a $5 million contractual milestone payment

Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What is the Nu.Q® Vet Cancer Test?

The Nu.Q® Vet Cancer Test is a diagnostic tool for detecting cancer in pets, particularly cats.

What milestone payment is associated with the Nu.Q® test?

The publication of the manuscript for the Nu.Q® Vet Cancer Test is expected to unlock a $5 million milestone payment.

Who collaborated with Volition on the Nu.Q® test?

Volition collaborated with Fujifilm Vet Systems to develop the first automated Nu.Q® Vet Cancer Test.

Where can I find updates on Volition's products?

You can subscribe for updates on Volition's products or check their investor updates and press releases.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare Nu.Q® veterinary cancer test Fujifilm Vet Systems milestone payment
Last updated: Apr 6, 2025

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk